Technical Analysis of Juno Therapeutics Inc. (NASDAQ:JUNO)

97

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Juno Therapeutics Inc. (NASDAQ:JUNO) for the period of 9-Day stands at 20.71% while the stochastic %D for the same period stands at 18.96%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Juno Therapeutics Inc. (NASDAQ:JUNO) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Juno Therapeutics Inc. (NASDAQ:JUNO) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Juno Therapeutics Inc. (NASDAQ:JUNO)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Juno Therapeutics, Inc. is a biopharmaceutical company. The Company develops cellular immunotherapies based on two platforms – Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Its clinical CD19 product candidates include JCAR015 that is in Phase I clinical trials for adult patients with relapsed/refractory B cell acute lymphoblastic leukemia (r/r ALL); JCAR017, which is in Phase I/II trials for pediatric patients with r/r ALL whose cancer has recurred after a bone marrow transplant; and JCAR014 that is in Phase I/II trials to treat various B cell malignancies in patients relapsed or refractory to standard therapies. Juno Therapeutics, Inc. is headquartered in Seattle, Washington.

Previous Day Activity Analysis

On the last trading day, Juno Therapeutics Inc. (NASDAQ:JUNO) opened the session at $42.75 and after going down -0.05% closed at $42.88. The stock gained 0.13 points in the last trade.

Juno Therapeutics Inc. (NASDAQ:JUNO)’s stock fluctuated in the range of $42.35 and $44.82 during the previous active session. Juno Therapeutics Inc. (NASDAQ:JUNO) traded with the volume of 1.17 Million with average volume of 2.61 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.91 and 55.98 respectively.

Currently the Insider Ownership of the shares of Juno Therapeutics Inc. (NASDAQ:JUNO) is at 1.8% and the shares outstanding are 112.13 Million.

Important Ratio Analysis

Some important ratios to consider here for Juno Therapeutics Inc. (NASDAQ:JUNO) are discussed below:

Dividend yield of Juno Therapeutics Inc. (NASDAQ:JUNO) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 58.21 and 4.78 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 6.89 and 0 correspondingly.

The Quick Ratio of Juno Therapeutics Inc. (NASDAQ:JUNO) stands at 5.1 while the Current Ratio depicts the value of 5.1.

Return on Assets ROA of Juno Therapeutics Inc. (NASDAQ:JUNO) is at -21.8% whereas, Return on Equity ROE and Return of Investment ROI of Juno Therapeutics Inc. (NASDAQ:JUNO) stand at -28.2% and -23% respectively.

Stock Performance Analysis

The stock performance of Juno Therapeutics Inc. (NASDAQ:JUNO) on the basis of 5 day trade show the dip of -1.83% whereas, the monthly performance of the stock shows decrease of -3.21%.

The quarterly performance of the stock remained in green zone with the value of 55.25% while six month performance of the shares of Juno Therapeutics Inc. (NASDAQ:JUNO) remained bullish with the count of 79.94%.

The yearly and YTD performance of Juno Therapeutics Inc. (NASDAQ:JUNO) remained up at 53.2% and 127.48% respectively.